Benedikt Pulver

EMCDDA framework and practical guidance for naming synthetic cannabinoids

Benedikt Pulver, Svenja Fischmann, Ana Gallegos et al. · Drug Testing and Analysis · 2022 · 34 citations

Drug Target, Emcdda Framework, Molecular Biology +16

Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB1 receptor activation assays. Part III: The G protein pathway and critical comparison of different assays

Katharina Elisabeth Grafinger, Marthe M. Vandeputte, Annelies Cannaert et al. · Drug Testing and Analysis · 2021 · 25 citations · Full text

Cumyl‐CBMICA: A new synthetic cannabinoid receptor agonist containing a cyclobutyl methyl side chain

Sebastian Halter, Benedikt Pulver, Maurice Wilde et al. · Drug Testing and Analysis · 2020 · 22 citations · Full text

New synthetic cannabinoids carrying a cyclobutyl methyl side chain: Human Phase I metabolism and data on human cannabinoid receptor 1 binding and activation of Cumyl‐CBMICA and Cumyl‐CBMINACA

Belal Haschimi, Katharina Elisabeth Grafinger, Benedikt Pulver et al. · Drug Testing and Analysis · 2021 · 21 citations · Full text

Return of the lysergamides. Part VII: Analytical and behavioural characterization of 1‐valeroyl‐<scp>d</scp>‐lysergic acid diethylamide (1V‐LSD)

Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal et al. · Drug Testing and Analysis · 2021 · 18 citations